Tag: assessment

BEERSE, BELGIUM, June 26, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced new data across 12 abstracts at the European Academy of Neurology (EAN) 2026 Congress that offer additional insight into the use of IMAAVY^®▼(nipocalimab) throughout clinically relevant points in the generalised myasthenia gravis (gMG) treatment journey. The analyses include adults with anti-AChR^a or anti-MuSK^b antibody-positive gMG who were early in their disease course or had lower baseline symptom burden – providing insight into the potential importance of addressing pathogenic immunoglobulin G (IgG) early in disease progression where use of advanced therapies may be less common.^1,2 Additional research to be shared include outcomes shortly after common infections, which are a known cause of disease exacerbations in gMG, and plans to address evidence gaps in the use of nipocalimab during pregnancy.^3,4

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.

Memorandum of Understanding signed today establishes a framework to explore mechanisms for investors in Ukraine to access Kyivstar’s existing Nasdaq-listed shares

Partnership aims to integrate Ukraine’s capital markets with global financial infrastructure and advance capital markets cooperation

LONDON, June 26, 2026 (GLOBE NEWSWIRE) -- Frontier Power UK, the long duration energy storage platform established as a joint venture between Frontier Power Ltd. and affiliates of Cerberus Capital Management, L.P. (“Cerberus”), today welcomed Ofgem’s provisional assessment of projects submitted to the Window 1 Long Duration Electricity Storage (“LDES”) Cap and Floor scheme.